Nyxoah (NYXH) Net Income towards Common Stockholders (2021 - 2026)
Nyxoah (NYXH) posted Net Income towards Common Stockholders of -$38.3 million for Q2 2026, down 105.27% on a QoQ basis from -$18.7 million in Q1 2026, and down 64.26% year-over-year from -$107.2 million in Q2 2025.
Powered by 
Analysis
Nyxoah (NYXH) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Nyxoah has reported Net Income towards Common Stockholders for 6 years, with the latest figure at -$38.3 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 64.26% year-over-year to -$38.3 million in Q2 2026; TTM through Jun 2026 was -$111.9 million, a 33.35% decrease from a year earlier, with the FY2025 full-year figure at -$101.8 million, down 58.75% from the prior year.
- Net Income towards Common Stockholders was -$38.3 million for Q2 2026 at Nyxoah, down from -$18.7 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $14.2 million in Q2 2024, with the low at -$38.3 million in Q2 2026.
- Average Net Income towards Common Stockholders over 5 years is -$15.2 million, with a median of -$13.8 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders surged 202.06% in 2024, then slumped 264.02% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$13.6 million in 2022, then rose by 13.6% to -$11.7 million in 2023, then plunged by 56.36% to -$18.3 million in 2024, then plunged by 49.36% to -$27.4 million in 2025, then tumbled by 39.99% to -$38.3 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$38.3 million (Q2 2026), -$18.7 million (Q1 2026), and -$27.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn | 249.10 Mn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn | 383.43 Mn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn | - |
| 10 | Nyxoah | 63.68 Mn | -49.98 Mn | 5.33 Mn | -38.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.32 Mn |
| Mar 31, 2026 | -18.67 Mn |
| Dec 31, 2025 | -27.37 Mn |
| Sep 30, 2025 | -27.57 Mn |
| Jun 30, 2025 | -23.33 Mn |
| Mar 31, 2025 | -23.55 Mn |
| Dec 31, 2024 | -18.33 Mn |
| Sep 30, 2024 | -18.73 Mn |
| Jun 30, 2024 | 14.22 Mn |
| Mar 31, 2024 | -12.93 Mn |
| Dec 31, 2023 | -11.72 Mn |
| Sep 30, 2023 | -8.29 Mn |
| Jun 30, 2023 | -13.93 Mn |
| Mar 31, 2023 | -12.78 Mn |
| Dec 31, 2022 | -13.57 Mn |
| Sep 30, 2022 | -6.29 Mn |
| Jun 30, 2022 | -5.32 Mn |
| Mar 31, 2022 | -7.52 Mn |
| Dec 31, 2021 | -7.15 Mn |
| Sep 30, 2021 | -10.33 Mn |
API Access
Nyxoah Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NYXH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NYXH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NYXH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();